A Non-aminoglycoside Semi-synthetic Site specific Antibiotic
Reduces the development of drug-resistant bacteria.
Maintains the effectiveness of antibacterial action at infected site.
Treats or prevents infections that are proven or strongly suspected to be caused by susceptible bacteria in Travelers' diarrhoea & Irritable bowel syndrome.
Effectively used for treatment of travelers' diarrhoea caused by noninvasive strains of Escherichia coli in adults and pediatric patients 12 years of age and older.
Ensures effective relief in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
